NeoGenomics, Inc. Accelerated Share Repurchase Program, Adjustment
NeoGenomics, Inc. (NEO) reported Accelerated Share Repurchase Program, Adjustment of $2.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Shareholders' Equity
us-gaap:AcceleratedShareRepurchaseProgramAdjustment · last filed 2026-02-17
- NeoGenomics, Inc. accelerated share repurchase program, adjustment for the quarter ending 2022-03-31 was $5.90M.
- NeoGenomics, Inc. accelerated share repurchase program, adjustment for fiscal 2025 was $2.90M, a 383.33% increase from fiscal 2024.
- NeoGenomics, Inc. accelerated share repurchase program, adjustment for fiscal 2024 was $600.00K, a 33.33% decline from fiscal 2023.
- NeoGenomics, Inc. accelerated share repurchase program, adjustment for fiscal 2023 was $900.00K, a 89.53% decline from fiscal 2022.
- NeoGenomics, Inc. accelerated share repurchase program, adjustment for fiscal 2022 was $8.60M, a 30.30% increase from fiscal 2021.
| Period end | Accelerated Share Repurchase Program, Adjustment 3 month | Accelerated Share Repurchase Program, Adjustment 12 month |
|---|---|---|
| 2025-12-31 | $2.90M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $600.00K 10-K · filed 2026-02-17 | |
| 2023-12-31 | $900.00K 10-K · filed 2025-02-18 | |
| 2022-12-31 | $8.60M 10-K · filed 2023-02-24 | |
| 2022-03-31 | $5.90M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $6.60M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |